Clinical Trial Update: Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating autologous CD19 CAR T-cell therapy for severe refractory systemic lupus erythematosus, and the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Autologous CD19 CAR-T cell therapy (CD19-directed CAR-T cell)

Snippet

Sponsor: National University of Malaysia | Conditions: Systemic Lupus Erythematous (SLE) | Phase 1 | Status: RECRUITING